Effectiveness and safety of probiotic therapy for pediatric allergic rhinitis management: A systematic review and meta-analysis

作者全名："Wang, Xia; Tan, Xiangsheng; Zhou, Jiwei"

作者地址："[Wang, Xia] Army Med Univ, Affiliated Hosp 2, Xinqiao Hosp, Dept Pediat, Chongqing 400037, Peoples R China; [Tan, Xiangsheng] Army Med Univ, Hosp Affiliated 1, Chongqing 400038, Peoples R China; [Zhou, Jiwei] Chongqing Med Univ, Dept Gen Practice, Childrens Hosp, Chongqing 400014, Peoples R China; [Zhou, Jiwei] Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Key Lab Child Dev & Disorders, Childrens Hosp,China Int Sci & Technol Cooperat Ba, Chongqing 400014, Peoples R China; [Zhou, Jiwei] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China"

通信作者："Zhou, JW (通讯作者)，Chongqing Med Univ, Dept Gen Practice, Childrens Hosp, Chongqing 400014, Peoples R China."

来源：INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000860519500004

JCR分区：Q2

影响因子：1.5

年份：2022

卷号：162

期号：　

开始页：　

结束页：　

文献类型：Review

关键词：Allergic rhinitis; Probiotics; Pediatric; Immune

摘要："Objective: This meta-analysis aimed to evaluate the effectiveness and safety of probiotics for allergic rhinitis (AR) management in children.Methods: In total, 6 databases were searched, and 26 randomized controlled trials that compared the effects of probiotics with those not using probiotics in pediatric AR were included. Methodological quality was assessed using the Cochrane risk-of-bias tool. Data for relevant endpoints were extracted and analyzed.Results: Our meta-analysis of the effectiveness of probiotics for pediatric AR showed that probiotics improved the remission rate of nasal symptoms (risk ratio (RR) 1.21, 95% confidence interval (CI) 1.04 to 1.40; P = 0.01), reduced the Total Nasal Symptoms Scores (TNSS) (weighted mean difference (WMD)-2.58, 95% CI-2.77 to-2.39; P < 0.00001) and the total scores of Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ) (for frequency of symptoms: WMD-9.51, 95% CI-10.34 to-8.69; P < 0.00001; and for level of bother: WMD-9.27, 95% CI-10.13 to-8.41; P < 0.00001). Furthermore, they reduced the serum levels of interleukin-4 (IL-4) (WMD-13.86 ng/L, 95% CI-15.92 to-11.81; P < 0.00001), IL-6 (WMD-13.70 pg/mL, 95% CI-16.34 to-11.07; P < 0.00001), and IL-17(WMD-5.41 pg/mL, 95% CI-7.29 to-3.52; P < 0.00001), and significantly elevated the serum levels of interferon-gamma (WMD 9.08 ng/L, 95% CI 8.10 to 10.06; P < 0.00001) and IL-10 (WMD 7.82 pg/mL, 95% CI 5.01 to 10.63; P < 0.00001). Probiotics also reduced the duration of cetirizine use in pediatric AR (WMD-2.88 days, 95% CI-4.50 to-1.26; P < 0.0005). No obvious adverse reactions were found to be related to probiotic treatment.Conclusions: This meta-analysis indicated that probiotic therapy can partially improve pediatric AR outcomes, assisted by modulating immune balance and reducing anti-allergic medication use, without obvious adverse reactions."

基金机构：　

基金资助正文：